Sri Ambikare Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mahbubnagar, Telangana, India, established in 2007.
2007 Mahbubnagar, Telangana, India Active
Last Updated:
Access Report
About Sri Ambikare Pharma Private Limited

Sri Ambikare Pharma Private Limited, a active private limited company, was established on 06 November 2007 in Mahbubnagar, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2007PTC056228. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹16.00 Cr and a paid-up capital of ₹3.00 Cr.

Formerly known as Leesa Lifesciences Private Limited. It upholds a compliant status. Its leadership includes Kasthur Reddy Nemallapudi (Director), Ramadevi Nemallapudi (Director). Past directors included Grandhi Venkata Rao, Naveen Kumar Naraharisetty, Venkata Varaprasad Rao Gupta Kothuri. It holds no open charges and ₹21.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at P2,Sy.No.423(P) 424(P) And 425(P), Jedcherla Mandal, Polepally, Mahbubnagar, Telangana, 509203.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2007PTC056228

  • Registration Number

    056228

  • Incorporation Date

    06 November 2007

  • Authorized Capital

    ₹16.00 Cr

  • Paid-Up Capital

    ₹3.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 16.00 Cr
  • Paid Up Capital ₹ 3.00 Cr
  • Company Age 18 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 21.50 Cr
  • Revenue Growth **** 189.22%
  • Profit Growth **** 69.69%
  • Ebitda **** 87.89%
  • Net Worth -0.18%
  • Total Assets **** 72.53%
Company report

Sri Ambikare Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sri Ambikare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sri Ambikare Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Kasthur Reddy Nemallapudi Director 18 Oct 2022 Current
Ramadevi Nemallapudi Director 18 Oct 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Jul 2011 Past
Pramod Abcsdd Additional Director 03 Mar 2012 Past
Pramod Abcsdd Director 18 Oct 2022 Past
Pramod Abcsdd Director 10 Jul 2008 Past
Pramod Abcsdd Director 30 Sep 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sri Ambikare Pharma.

Leesa Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 189.22% increase. The company also saw a substantial improvement in profitability, with a 69.69% increase in profit. The company's net worth dipped by a decrease of 0.18%.

Sri Ambikare Pharma revenue growth over time
Sri Ambikare Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 189.22%
*******
*******
*******
*******
Revenue from Operations
*******
 203.07%
*******
*******
*******
*******
Total Assets
*******
 72.53%
*******
*******
*******
*******
Profit or Loss
*******
 69.69%
*******
*******
*******
*******
Net Worth
*******
 -0.18%
*******
*******
*******
*******
EBITDA
*******
 87.89%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sri Ambikare Pharma?

In 2024, Sri Ambikare Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹215,000,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 21.50 Cr
Latest Charge Details
Date Lender Amount Status
08 Dec 2009 State Bank Of India ₹21.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sri Ambikare Pharma?

Unlock and access historical data on people associated with Sri Ambikare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sri Ambikare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Ambikare Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sri Ambikare Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sri Ambikare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Sri Ambikare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Charges

    The activity A charge registered on 08 Dec 2009 via Charge ID 10188705 with State Bank Of India was fully satisfied on 06 Jan 2023. was completed.

  • Director Appointment

    Progress on Kasthur Reddy Nemallapudi was appointed as a Director was appointed as a Director on 18 Oct 2022 & has been associated with this company since 3 years 4 months . was documented.

  • Director Appointment

    The activity Ramadevi Nemallapudi was appointed as a Director was appointed as a Director on 18 Oct 2022 & has been associated with this company since 3 years 4 months . was completed.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 21.50 Cr registered on 08 Dec 2009 with Charge ID 10188705 was modified on 28 Sep 2011. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sri Ambikare Pharma Private Limited?

The CIN of Sri Ambikare Pharma Private Limited is U24232TG2007PTC056228.

Where is Sri Ambikare Pharma Private Limited headquartered?

Sri Ambikare Pharma Private Limited is headquartered at P2,Sy.No.423(P) 424(P) And 425(P), Jedcherla Mandal, Polepally, Mahbubnagar, Telangana, 509203.

When was Sri Ambikare Pharma Private Limited incorporated?

Sri Ambikare Pharma Private Limited was incorporated on 06 November 2007.

Who are the current directors of Sri Ambikare Pharma Private Limited?

The current directors of Sri Ambikare Pharma Private Limited are

What is the primary industry of Sri Ambikare Pharma Private Limited?

The primary industry of Sri Ambikare Pharma Private Limited is Manufacturing.

Is Sri Ambikare Pharma Private Limited a listed company?

Sri Ambikare Pharma Private Limited is unlisted.

What is the capital structure of Sri Ambikare Pharma Private Limited?

The authorized capital of Sri Ambikare Pharma Private Limited is ₹16.00 Cr, and the paid-up capital is ₹3.00 Cr.

What is the compliance status of Sri Ambikare Pharma Private Limited?

The compliance status of Sri Ambikare Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available